The prognostic utility of dihomo-gamma-linolenic acid (DGLA) in patients with acute coronary heart disease - PubMed (original) (raw)

Observational Study

The prognostic utility of dihomo-gamma-linolenic acid (DGLA) in patients with acute coronary heart disease

Dennis W T Nilsen et al. Int J Cardiol. 2017.

Abstract

Background: We previously investigated the prognostic utility of red blood cell (RBC) n-3 fatty acids (FAs) in survivors of an acute myocardial syndrome (ACS) but found no relationship with all-cause mortality and cardiac death or MI after two years. Here we extend our follow-up to 7years, focusing on the potential predictive power of RBC n-6 FAs.

Methods: We included 398 ACS patients presenting with increased troponin-T (TnT) levels for whom baseline RBC FA data were available. Cox regression analysis was used to relate the risk of future events to RBC n-6 FA levels, both continuously and by quartile.

Results: At 7-year follow-up, 183 (46.0%) had died, 128 (32.2%) had experienced another MI and 24 (6.0%) had had a stroke. Death or MI occurred in 227 patients (57.0%); and death, MI or stroke in 235 patients (59.0%). In a multivariable Cox regression model for total death, the hazard ratio (HR) in the highest as compared to the lowest quartile of dihomo-γ-linolenic acid (DGLA) was 0.55 [95% confidence interval (CI), 0.35-0.88, p=0.012, for death or MI [HR 0.62 (95% CI, 0.41-0.94), p=0.025], and for the fully combined endpoint [HR 0.57 (95% CI, 0.38-0.86), p=0.006]. Similar results were found in the per 1-SD analysis. No other RBC n-6 FAs significantly predicted these outcomes in multivariable models.

Conclusion: RBC DGLA levels had significant independent prognostic value in post-ACS patients. These findings need confirmation, and the possible biochemical pathways by which higher DGLA membrane levels may be cardioprotective should be explored.

Keywords: Acute coronary syndrome (ACS); Dihomo-gamma-linolenic acid (DGLA); Myocardial infarction (MI); Prognosis; Stroke; Total mortality.

PubMed Disclaimer

Cited by

Serum Levels of Dihomo-Gamma (γ)-Linolenic Acid (DGLA) Are Inversely Associated with Linoleic Acid and Total Death in Elderly Patients with a Recent Myocardial Infarction.
Nilsen DWT, Myhre PL, Kalstad A, Schmidt EB, Arnesen H, Seljeflot I. Nilsen DWT, et al. Nutrients. 2021 Sep 30;13(10):3475. doi: 10.3390/nu13103475. Nutrients. 2021. PMID: 34684479 Free PMC article. Clinical Trial.
Individual fatty acids in erythrocyte membranes are associated with several features of the metabolic syndrome in obese children.
Bonafini S, Tagetti A, Gaudino R, Cavarzere P, Montagnana M, Danese E, Benati M, Ramaroli DA, Raimondi S, Giontella A, Mantovani A, Donato A, Dalbeni A, Minuz P, Antoniazzi F, Maffeis C, Fava C. Bonafini S, et al. Eur J Nutr. 2019 Mar;58(2):731-742. doi: 10.1007/s00394-018-1677-2. Epub 2018 Mar 28. Eur J Nutr. 2019. PMID: 29594475
Evening Primrose (Oenothera biennis) Biological Activity Dependent on Chemical Composition.
Timoszuk M, Bielawska K, Skrzydlewska E. Timoszuk M, et al. Antioxidants (Basel). 2018 Aug 14;7(8):108. doi: 10.3390/antiox7080108. Antioxidants (Basel). 2018. PMID: 30110920 Free PMC article. Review.
Free Fatty Acids and Their Inflammatory Derivatives Affect BDNF in Stroke Patients.
Kotlega D, Zembron-Lacny A, Morawin B, Golab-Janowska M, Nowacki P, Szczuko M. Kotlega D, et al. Mediators Inflamm. 2020 Dec 3;2020:6676247. doi: 10.1155/2020/6676247. eCollection 2020. Mediators Inflamm. 2020. PMID: 33343231 Free PMC article.
Dietary Supplementation With ω6 LC-PUFA-Rich Algae Modulates Zebrafish Immune Function and Improves Resistance to Streptococcal Infection.
Nayak S, Khozin-Goldberg I, Cohen G, Zilberg D. Nayak S, et al. Front Immunol. 2018 Sep 6;9:1960. doi: 10.3389/fimmu.2018.01960. eCollection 2018. Front Immunol. 2018. PMID: 30237797 Free PMC article.

The prognostic utility of dihomo-gamma-linolenic acid (DGLA) in patients with acute coronary heart disease - PubMed (original) (raw)